Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers for Event-driven PrEP Adherence
NCT04298697Phase 4Completed
- Sponsor
- Emory University
- Start
- Feb 2020
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by Emory University. Started Feb 2020; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04298697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04298697.